Human Proteins Behind COVID-19 Infection Revealed by Innovative CRISPR Technology

In the quest for new treatments for COVID-19, a team led by UCSF researchers identified a new potential drug target that may prevent infection of human cells by SARS-CoV-2.

Alpha Coronavirus Variant Evolved to Evade Immune System

A new study led by scientists at UCSF's Quantitative Biosciences Institute and University College London found that the Alpha variant of SARS-CoV-2 ramped up production of a protein that it uses to stifle infected cells’ immune-stimulating signals, helping it evade immune detection and accelerate...

As Omicron Surges, UCSF Experts Answer Questions About the COVID-19 Variant

There is some information that is known about the variant and other information that sti

COVID Patients on SSRI Antidepressants Are Less Likely to Die, UCSF-Stanford Study Finds

A UCSF and Stanford study of electronic health records linked SSRIs, the most widely prescribed antidepressants, to survival for COVID-19 patients.

Community-Based Strategy Succeeds in Vaccinating Latinx San Franciscans 

A community-based effort to overcome vaccine hesitancy  designed by UCSF scientists working together with San Francisco’s Latino Task Force is succeeding in the Mission District of San Francisco. 

UCSF begins offering flu vaccines at several UCSF locations

Flu Vaccine Schedule

COVID-19 During Pregnancy Associated with Preterm Birth

Individuals who contract COVID-19 while pregnant face a higher risk of having a very preterm birth, as well as any preterm birth.

UCSF Responds to Surge in COVID-19 Cases Among Employees, Learners

UCSF is responding to an increase in the number of community-acquired COVID-19 cases among its employees and learners.

UCSF to House COVID Tracking Project, a National Database Donated by The Atlantic

UCSF and The Atlantic have announced that the crowdsourced digital archive documenting the face of the pandemic in the United States will become part of the University’s permanent library collection and is accessible to researchers and the public.

AIDS at 40: Sexism, Structural Racism and Discrimination Continues for HIV and COVID-19

This is one of the first-person perspectives from those who are working on the frontlines to better understand, treat and prevent transmission of HIV and AIDS as well as COVID-19.